Sean Pinney to Cardiovascular Agents
This is a "connection" page, showing publications Sean Pinney has written about Cardiovascular Agents.
Connection Strength
0.284
-
Rationale and Design of the EMPA-TROPISM Trial (ATRU-4): Are the "Cardiac Benefits" of Empagliflozin Independent of its Hypoglycemic Activity? Cardiovasc Drugs Ther. 2019 02; 33(1):87-95.
Score: 0.166
-
High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg. 2005 Aug; 80(2):502-6.
Score: 0.065
-
The Clinical Use of Ivabradine. J Am Coll Cardiol. 2017 Oct 03; 70(14):1777-1784.
Score: 0.038
-
Recent diagnostic and therapeutic innovations in heart failure management. Mt Sinai J Med. 2005 May; 72(3):176-84.
Score: 0.016